CD44+CD24− Prostate Cells Are Early Cancer Progenitor/Stem Cells That Provide a Model for Patients With Poor Prognosis

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6604242
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

CD44/CD24 and Aldehyde Dehydrogenase 1 in Estrogen Receptor-Positive Early Breast Cancer Treated With Tamoxifen: CD24 Positivity Is a Poor Prognosticator

Oncotarget
Oncology
2017English

Prostate Cancer Stem Cells

Clinical Genitourinary Cancer
OncologyUrology
2012English

Basal Epithelial Stem Cells Are Efficient Targets for Prostate Cancer Initiation

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2010English

Oct-4 and Nanog Promote the Epithelial-Mesenchymal Transition of Breast Cancer Stem Cells and Are Associated With Poor Prognosis in Breast Cancer Patients

Oncotarget
Oncology
2014English

Stem-Like and Highly Invasive Prostate Cancer Cells Expressing CD44v8-10 Marker Originate From CD44-negative Cells

Oncotarget
Oncology
2018English

Disseminated Prostate Cancer Cells Can Instruct Hematopoietic Stem and Progenitor Cells to Regulate Bone Phenotype

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2012English

SLUG/SNAI2 and Tumor Necrosis Factor Generate Breast Cells With CD44+/CD24- Phenotype

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

The microRNA miR-34a Inhibits Prostate Cancer Stem Cells and Metastasis by Directly Repressing CD44

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

Prostate Cancer Stem Cells: Current Understanding

Stem Cells
MedicineMolecular MedicineDevelopmental BiologyCell Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy